Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2022

Jan 4, 2022

34472_dirs_2022-01-04_181efcf7-7e91-4a3f-8bcd-5b0cc2c89a0b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2021-12-30

Reporting Person: SCHULER JACK W (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-30 Common Stock P 2298850 $4.35 Acquired 8463164 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 277777 Indirect

Footnotes

F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2: The Reporting Person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the Reporting Person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the Reporting Person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.